Business

Authored by Kyle Plantz via InsideSources.com,

U.S. Sen. Claire McCaskill, D-Mo., opened an investigation Tuesday into the role drug companies may have played in the nation’s opioid epidemic. She requested internal documents from five leading drugmakers on how they market opioid painkillers and if they knew anything about the dangers of the drugs. Yet, the top opioid prescription manufacturer, which is located in McCaskill’s home state in St. Louis, Missouri, is missing from the initial list of companies she’s investigating.

It's not just the HFT industry that has cannibalized itself so much, while spooking regular traders out of the markets, there is hardly any revenue growth left (as the WSJ showed last week). After suffering a substantial drop in bank equity trading revenues over the past several years, there was hope that finally this key P&L items of sales and trading would post a modest pick up.

Authored by Charles Hugh Smith via OfTwoMinds blog,

Central bank policies have generated a truly unprecedented "trickle-up" of wealth and income to the top .5%.

Market narratives are myths.

Look at this chart. Which asset class would have been better to own in 2017 thus far… the blue line or the black line?

It’s obviously a no brainer, the black line has nearly doubled the blue line’s performance year to date.

Here’s the chart with legends included. Surprised?

Is the Trump trade alive or dead: that is the question Bank of America analyst Savita Subramanian tries to answer in a report overnight, in which she notes that it is not one Trump trade but several, and they tend to be "harder to isolate."